Transense Technologies PLC Director/PDMR Shareholding (2393V)

TIDMTRT

RNS Number : 2393V

Transense Technologies PLC

30 November 2023

30 November 2023

Transense Technologies plc

("Transense", or the "Company")

Director/PDMR shareholdings - acquisition of shares

Transense Technologies plc, the provider of specialist sensing solutions and measurement systems, has been notified that the wife of Nigel Rogers, Executive Chairman of the Company, has purchased 6,500 ordinary shares in the Company yesterday, at 94.275 pence per share.

Accordingly, Nigel Rogers' total beneficial shareholding in the Company has increased to 271,500 ordinary shares, which represents approximately 1.75% of the Company's current voting rights.

Further details are provided in the forms below in accordance with the requirements of the UK Market Abuse Regulation.

For further information please visit www.transense.com or contact:

 
 Transense Technologies plc                 Via Walbrook PR 
  Nigel Rogers (Executive Chairman) 
  Melvyn Segal (CFO) 
 Allenby Capital (Nominated Adviser and     Tel: [phone] 
  Broker)                                    5656 
  Jeremy Porter / George Payne (Corporate 
  Finance) 
  Stefano Aquilino / Tony Quirke (Sales & 
  Corporate Broking) 
 Walbrook PR                                Tel: [phone] 
  Tom Cooper/Nick Rome/Joe Walker            8780 
                                             [e-mail] 
 

Notes to Editors:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, automotive (high performance and off-road) and complex machine control.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact [e-mail].

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                          Julie Rogers 
     ----------------------------  ---------------------------------- 
 2    Reason for the notification 
     ---------------------------------------------------------------- 
 a)   Position/status               Person closely associated with 
                                     Executive Chairman 
     ----------------------------  ---------------------------------- 
 b)   Initial notification          Initial 
       /Amendment 
     ----------------------------  ---------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ---------------------------------------------------------------- 
 a)   Name                          Transense Technologies plc 
     ----------------------------  ---------------------------------- 
 b)   LEI                           2138005N52J6KKQ3EY67 
     ----------------------------  ---------------------------------- 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
     ---------------------------------------------------------------- 
 a)   Description of the            Ordinary Shares of 10 pence each 
       financial instrument, 
       type of instrument 
 
      Identification code           GB00BDHDTH21 
 
 b)   Nature of the transaction     Purchase of Ordinary Shares 
     ----------------------------  ---------------------------------- 
 c)   Price and volume              Price: 94.275 pence per share 
 
                                     Volume: 6,500 
     ----------------------------  ---------------------------------- 
 d)   Aggregated information 
 
      - Aggregated volume           As above 
 
      - Price 
 
 e)   Date of the transaction       29 November 2023 
     ----------------------------  ---------------------------------- 
 f)   Place of the transaction      London Stock Exchange, AIM 
     ----------------------------  ---------------------------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFLLLILIVIV

(END) Dow Jones Newswires

November 30, 2023 06:11 ET (11:11 GMT)